Weiwei Zou

870 total citations
31 papers, 647 citations indexed

About

Weiwei Zou is a scholar working on Molecular Biology, Surgery and Biomaterials. According to data from OpenAlex, Weiwei Zou has authored 31 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Biomaterials. Recurrent topics in Weiwei Zou's work include RNA Interference and Gene Delivery (5 papers), MicroRNA in disease regulation (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Weiwei Zou is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), MicroRNA in disease regulation (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Weiwei Zou collaborates with scholars based in China, Australia and France. Weiwei Zou's co-authors include Na Zhang, Chunxi Liu, Zhijin Chen, Xiaopeng Xiong, Tielong Liu, Jiangjiang Duan, Yanwei Xi, Guangqing Cao, Guanghui Chen and Yun Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Weiwei Zou

28 papers receiving 642 citations

Peers

Weiwei Zou
Comparison fields: 5 of 108
  • Molecular Biology 285
  • Biomaterials 157
  • Cancer Research 155
  • Biomedical Engineering 95
  • Pharmaceutical Science 93
Replace Shan Zong with:
Shan Zong China
Jiandong Yuan China
Tong An China
Yoshie Arai South Korea
Kemal Baysal Türkiye
Yang Tan China
Van Quy Nguyen South Korea
Stephen C. Yang United States
Nickolay Koroukhov Israel
Ali Fotouhi Iran
Shan Zong China View profile →
Citations per field, relative to Weiwei Zou
Weiwei Zou · 1×
Citations per year, relative to Weiwei Zou
Weiwei Zou · 1×

Countries citing papers authored by Weiwei Zou

Since Specialization
Citations

This map shows the geographic impact of Weiwei Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Zou more than expected).

Fields of papers citing papers by Weiwei Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Zou. The network helps show where Weiwei Zou may publish in the future.

Co-authorship network of co-authors of Weiwei Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Zou. A scholar is included among the top collaborators of Weiwei Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Zou. Weiwei Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 0
4 4
5 0
6 6
7 7
8 38
9 43
10 6
11 39
12 56
13 18
14 17
15 50
16 30
17 51
18 28
19 59
20 40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026